AI-Based Speech Intelligibility Assessment: Efficacy & Reliability
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Patients With Speech Disorders. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Clinical Study on the Efficacy and Reliability of Speech Intelligibility Assessment for Post-stroke Patients Using an AI Solution
Overview
compare the auditory-perceptual assessment conducted by speech-language pathologists using the U-TAP with the assessment performed via the AI solution (Blings) program in patients with speech disorders, and to evaluate the efficacy and reliability of these two methods for speech intelligibility assessment.
Primary outcome measures
- Word-level consonant accuracy (%) derived from speech samples obtained during the U-TAP assessment [Time frame: Visit 1 (Baseline)]
Secondary outcome measures (3)
- Test-retest reliability of word-level consonant accuracy (%) calculated by Blings [Time frame: Visit 1 and Visit 2 (7 ± 5 days interval)]
- Inter-rater agreement of word-level consonant accuracy (%) among Blings, Rater 1, and Rater 2 [Time frame: Visit 1 and Visit 2 (7 ± 5 days interval)]
- Time required to complete speech analysis (seconds) [Time frame: Visit 1 and Visit 2 (7 ± 5 days interval)]
Eligibility criteria
Inclusion criteria
- Adults aged 18 years or older.
- Patients with neurologic disorders, including amyotrophic lateral sclerosis, poliomyelitis, cerebellar disorders, cerebellar lesions, and stroke.
- Patients presenting with concomitant speech disorders, such as dysarthria, motor speech disorders, and voice disorders.
Exclusion criteria
- Subjects with a score of less than 16 points on the Korean Mini-Mental State Examination (K-MMSE).
- Subjects with visual, perceptual, or auditory impairments that prevent them from following the examiner's instructions.
- Subjects judged by the researcher as unsuitable for participation in this clinical study due to other reasons.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07347782 · 11-2025-086